ATE241630T1 - Verfahren zur herstellung von ucn-01 - Google Patents

Verfahren zur herstellung von ucn-01

Info

Publication number
ATE241630T1
ATE241630T1 AT99125341T AT99125341T ATE241630T1 AT E241630 T1 ATE241630 T1 AT E241630T1 AT 99125341 T AT99125341 T AT 99125341T AT 99125341 T AT99125341 T AT 99125341T AT E241630 T1 ATE241630 T1 AT E241630T1
Authority
AT
Austria
Prior art keywords
ucn
producing
acidified
producing ucn
solution
Prior art date
Application number
AT99125341T
Other languages
German (de)
English (en)
Inventor
Akihito Nagamura
Hidenori Aoki
Mitsutaka Kino
Toshimitsu Takiguchi
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE241630T1 publication Critical patent/ATE241630T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
AT99125341T 1998-12-22 1999-12-21 Verfahren zur herstellung von ucn-01 ATE241630T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10364369A JP2000186092A (ja) 1998-12-22 1998-12-22 Ucn−01の製造法

Publications (1)

Publication Number Publication Date
ATE241630T1 true ATE241630T1 (de) 2003-06-15

Family

ID=18481646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99125341T ATE241630T1 (de) 1998-12-22 1999-12-21 Verfahren zur herstellung von ucn-01

Country Status (6)

Country Link
US (1) US6197955B1 (enExample)
EP (1) EP1020471B1 (enExample)
JP (1) JP2000186092A (enExample)
AT (1) ATE241630T1 (enExample)
CA (1) CA2293023A1 (enExample)
DE (1) DE69908288T2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887864B2 (en) 2002-03-12 2005-05-03 Hoffmann-La Roche Inc. Azepane derivatives
PL1651612T3 (pl) 2003-07-22 2012-09-28 Astex Therapeutics Ltd Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
AU2006207325B2 (en) * 2005-01-21 2012-08-16 Astex Therapeutics Limited Pharmaceutical compounds
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220196A (ja) 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ucn―01
EP0383919A4 (en) 1988-02-04 1992-08-05 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
EP0575955B1 (en) * 1992-06-22 1999-09-15 Kyowa Hakko Kogyo Co., Ltd. Process for producing staurosporine derivatives

Also Published As

Publication number Publication date
JP2000186092A (ja) 2000-07-04
DE69908288T2 (de) 2004-04-08
DE69908288D1 (de) 2003-07-03
US6197955B1 (en) 2001-03-06
CA2293023A1 (en) 2000-06-22
EP1020471A1 (en) 2000-07-19
EP1020471B1 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
ATE121066T1 (de) Verfahren zur herstellung von 6,12-dihydro-6- hydroxy-cannabidiol und dessen anwendung zur herstellung von trans-delta-9- tetrahydrocannabinol.
DE69908998D1 (de) Verfahren zur Herstellung von Kohlenstoff
DE69101775D1 (de) Verfahren zur Herstellung von Wasserstoffperoxid.
DE69623550D1 (de) Verfahren zur Herstellung von Graphitfasern
ATE162551T1 (de) Verfahren zur herstellung von dihomo-gamma- linolensäure und das in dieser enthaltende lipid
DE68916086D1 (de) Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen.
DE69521175D1 (de) Verfahren zur Herstellung von Xanthangummi
DE69007800D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
DE69020172D1 (de) Verfahren zur Herstellung von epsilon-Caprolactam.
ATE101144T1 (de) Verfahren zur herstellung von cyclischen sulfaten.
DE3689613D1 (de) Verfahren zur Herstellung von geschnittenen Strängen aus Kohlenstoffasern.
ATE427359T1 (de) 5'-inosinsaure herstellender mikroorganismus und verfahren zur herstellung von 5'- inosinsaure unter verwendung desselben
DE69903443D1 (de) Kontinuierliches Verfahren zur Herstellung von optisch reinem (S)-3-Hydroxy-gamma-Butyrolacton
ATE241630T1 (de) Verfahren zur herstellung von ucn-01
DE69620539D1 (de) Verfahren zur Reinigung von Thrombomodulin
DE59006645D1 (de) Verfahren zur kontinuierlichen herstellung von 3,3'-dichlor-benzidin-dihidrochlorid.
ATE262504T1 (de) Kontinuierliches isothermes verfahren zur herstellung von mononitrotoluolen
ATE277919T1 (de) Verfahren zur herstellung von baccatin iii- derivativen
ATE67986T1 (de) Verfahren zur herstellung von wasserstoffperoxid.
DE69317237D1 (de) Verfahren zur Herstellung von abriebfesten, transparenten Teilen
ATE174966T1 (de) Verfahren zur herstellung von biotin
ATE235461T1 (de) Verfahren zur herstellung von 3-cyano-2,4- dihalogen-5-fluor-benzoesäuren
DE59905165D1 (de) Verfahren zur Herstellung von Orthoestern
DE50105715D1 (de) Verfahren zur herstellung von dnda

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties